Robert B. Den

10.0k total citations · 1 hit paper
206 papers, 4.5k citations indexed

About

Robert B. Den is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Cancer Research. According to data from OpenAlex, Robert B. Den has authored 206 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Pulmonary and Respiratory Medicine, 48 papers in Radiation and 47 papers in Cancer Research. Recurrent topics in Robert B. Den's work include Prostate Cancer Treatment and Research (125 papers), Prostate Cancer Diagnosis and Treatment (93 papers) and Advanced Radiotherapy Techniques (47 papers). Robert B. Den is often cited by papers focused on Prostate Cancer Treatment and Research (125 papers), Prostate Cancer Diagnosis and Treatment (93 papers) and Advanced Radiotherapy Techniques (47 papers). Robert B. Den collaborates with scholars based in United States, Canada and Israel. Robert B. Den's co-authors include Adam P. Dicker, Elai Davicioni, Felix Y. Feng, Karen E. Knudsen, Nicholas G. Zaorsky, R. Jeffrey Karnes, Edouard J. Trabulsi, Eric A. Klein, Edward M. Schaeffer and Ashley E. Ross and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Robert B. Den

200 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy

2016 229 citations Felix Y. Feng, Robert B. Den et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert B. Den United States	36	3.1k	1.2k	1.2k	858	680	206	4.5k
Axel Semjonow Germany	35	2.6k 0.8×	746 0.6×	1.1k 0.9×	797 0.9×	366 0.5×	170	4.2k
Koichiro Akakura Japan	31	2.4k 0.8×	388 0.3×	650 0.6×	569 0.7×	318 0.5×	171	3.1k
Leslie A. Mangold United States	37	4.5k 1.5×	934 0.8×	1.2k 1.0×	811 0.9×	456 0.7×	91	5.8k
Thomas E. Stinchcombe United States	41	3.7k 1.2×	824 0.7×	1.7k 1.5×	3.9k 4.5×	660 1.0×	215	6.9k
Yuhchyau Chen United States	35	2.6k 0.8×	551 0.5×	682 0.6×	1.2k 1.5×	1.1k 1.6×	120	4.4k
Andrew Kramar France	41	1.1k 0.3×	809 0.7×	1.1k 0.9×	1.9k 2.3×	711 1.0×	102	4.6k
Stephan Störkel Germany	35	3.7k 1.2×	1.4k 1.2×	2.9k 2.5×	1.5k 1.8×	329 0.5×	123	5.8k
Michael L. Cher United States	42	2.5k 0.8×	1.6k 1.4×	1.9k 1.6×	2.0k 2.3×	437 0.6×	165	5.5k
Shin Egawa Japan	40	3.7k 1.2×	1.2k 1.0×	1.7k 1.4×	1.3k 1.5×	500 0.7×	360	6.4k
Gregory A. Masters United States	36	4.0k 1.3×	841 0.7×	1.3k 1.2×	4.1k 4.7×	586 0.9×	127	6.9k

Countries citing papers authored by Robert B. Den

Since Specialization

Citations

This map shows the geographic impact of Robert B. Den's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Den with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Den more than expected).

Fields of papers citing papers by Robert B. Den

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Den. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Den. The network helps show where Robert B. Den may publish in the future.

Co-authorship network of co-authors of Robert B. Den

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Den. A scholar is included among the top collaborators of Robert B. Den based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Den. Robert B. Den is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Furman, Ben, et al.. (2024). Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET/CT on radiotherapy decision-making in patients with node-positive disease. Cancer Imaging. 24(1). 96–96. 1 indexed citations

Mann, Mark, et al.. (2024). Complications and Influential Perioperative Factors Associated with SpaceOAR Hydrogel Placement. Advances in Urology. 2024(1). 3439727–3439727. 3 indexed citations

Liu, Deli, Michael A. Augello, Ivana Grbeša, et al.. (2021). Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer. Journal of Clinical Investigation. 131(10). 27 indexed citations

Rasool, Reyaz ur, Ramakrishnan Natesan, Qu Deng, et al.. (2019). CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation. Cancer Discovery. 9(11). 1538–1555. 86 indexed citations

Dicker, Adam P., Thierry de Baère, Caroline Hoffmann, et al.. (2019). Hafnium Oxide Nanoparticles Activated By Radiotherapy: Potential for Local Treatment of a Wide Variety of Solid Tumors. International Journal of Radiation Oncology*Biology*Physics. 105(1). S241–S241. 1 indexed citations

Thangavel, Chellappagounder, Ettickan Boopathi, Yi Liu, et al.. (2018). Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non–Small Cell Lung Cancer. Clinical Cancer Research. 24(6). 1402–1414. 39 indexed citations

Miyahira, Andrea K., Robert B. Den, Maria I. Carlo, et al.. (2018). Tumor cell heterogeneity and resistance; report from the 2018 Coffey‐Holden Prostate Cancer Academy Meeting. The Prostate. 79(3). 244–258. 12 indexed citations

Mahal, Brandon A., David D. Yang, Natalie Q. Wang, et al.. (2018). Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer. European Urology. 74(2). 146–154. 72 indexed citations

Yang, David D., Vinayak Muralidhar, Brandon A. Mahal, et al.. (2017). Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 35(9). 542.e25–542.e32. 3 indexed citations

10.

You, Sungyong, Beatrice S. Knudsen, Nicholas Erho, et al.. (2016). Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome. Cancer Research. 76(17). 4948–4958. 132 indexed citations

11.

Den, Robert B., Elai Davicioni, Mandeep Takhar, et al.. (2016). The Frequency of Druggable Targets in Localized Prostate Cancer: Initial Analysis From a Commercially Available Genomic Expression Database in Urologic Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E251–E252. 1 indexed citations

12.

Dan, Tu, et al.. (2016). Dosing, administration, and safety of radium-223: How I do it.. PubMed. 23(3). 8301–5. 2 indexed citations

13.

Zhao, Shuang G., Joseph R. Evans, Vishal Kothari, et al.. (2015). The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer. Clinical Cancer Research. 22(7). 1777–1786. 43 indexed citations

14.

Leeuw, Renée de, Lisa D. Berman-Booty, Matthew J. Schiewer, et al.. (2015). Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer. Clinical Cancer Research. 21(4). 795–807. 81 indexed citations

15.

Chen, Yu‐Wei, Brandon A. Mahal, Vinayak Muralidhar, et al.. (2015). Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 94(4). 683–690. 49 indexed citations

16.

Thangavel, Chellappagounder, Ettickan Boopathi, Yi Liu, et al.. (2014). The Retinoblastoma Tumor Suppressor Modulates DNA Repair and Radioresponsiveness. Clinical Cancer Research. 20(21). 5468–5482. 20 indexed citations

17.

Yamoah, Kosj, Harriet Eldredge-Hindy, Nicholas G. Zaorsky, et al.. (2014). Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 13(5). 456–464. 7 indexed citations

18.

Goodwin, Jonathan F., Matthew J. Schiewer, Jeffry L. Dean, et al.. (2013). A Hormone–DNA Repair Circuit Governs the Response to Genotoxic Insult. Cancer Discovery. 3(11). 1254–1271. 265 indexed citations

19.

Buzurović, Ivan, Timothy N. Showalter, Matthew T. Studenski, et al.. (2013). Commissioning and implementation of an implantable dosimeter for radiation therapy. Journal of Applied Clinical Medical Physics. 14(2). 234–252. 6 indexed citations

20.

Schiewer, Matthew J., Robert B. Den, David T. Hoang, et al.. (2011). mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer. Endocrine Related Cancer. 19(1). 1–12. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact